TABLE 1.
VZV straina | Genotype by the indicated method:b
|
Diseasec | Year isolated | Location | Dominant regiond | Accession no.e | ||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | ||||||
Dumas | E1 | C | A | V | 1970s | The Netherlands | Europe, North America, Australia | XO4370 |
BC | E1 | C | A | Z | 1999 | Canada | AY548171 | |
MSP | E1 | C | A | V | 1995 | United States | AY548170 | |
SD | E1 | C | A | NA | 1980 | United States | DQ479953 | |
KEL | E1 | C | A | Z | 2002 | United States | DQ479954 | |
36 | E1 | C | A | V | 1998 | Canada | DQ479958 | |
49 | E1 | C | A | V | 1999 | Canada | DQ479959 | |
32 P5 | E1 | C | A | V | 1976 | United States | DQ479961 | |
32 P22 | E1 | C | A | NA | DQ479962 | |||
Russia | E1 | C | A | Z | Russia | NA | ||
NH293 | E1 | C | A | V | 2000 | United States | DQ674250 | |
HJO | E2 | B | D | Z | 1990s | Germany | Not dominant in any region | AJ871403 |
11 | E2 | B | D | Z | 1996 | Canada | DQ479955 | |
22 | E2 | B | D | Z | 1998 | Canada | DQ479956 | |
03-500 | E2 | B | D | NA | 2003 | Canada | DQ479957 | |
CA123 | M1 | A | V | 1990s | United States | Central Africa | DQ457052 | |
DR | M2 | J1 | C | Z | United States | Indochina | DQ452050 | |
8 | M2 | J1 | C | Z | 1995 | Canada | DQ479960 | |
pOkaf | J | J1 | B | V | 1970 | Japan | Japan | AB097933 |
vOka | AB097932 | |||||||
VarilRix | DQ008354 | |||||||
VariVax | DQ008355 |
Strains are grouped with reference strains (in boldface).
See text for a description of methods 1, 2, and 3.
V, varicella; Z, zoster; NA, disease condition of isolate is not available.
In the region(s), >50% of isolates are of the indicated genotype(s).
NA, not available.
vOka (Biken), VarilRix, and VariVax are all preparations of attenuated VZV derived from strain pOka.